866-997-4948(US-Canada Toll Free)

United States Prostate Cancer Therapeutic Market Report 2016

Published By :

QYResearch

Published Date : Sep 2016

Category :

Cancer

No. of Pages : 122 Pages

Notes:
Sales, means the sales volume of Prostate Cancer Therapeutic
Revenue, means the sales value of Prostate Cancer Therapeutic

This report studies sales (consumption) of Prostate Cancer Therapeutic in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)
ALZA Corporation (USA)
Amgen Inc. (USA)
AstraZeneca PLC (UK)
Medimmune, LLC (USA)
Bristol-Myers Squibb Company (USA)
Cell Genesys Inc. (USA)
Dendreon Corporation (USA)
EUSA Pharma, (USA) Inc. (USA)
F. Hoffmann-La Roche Ltd. (Switzerland)
Progenics Pharmaceuticals, Inc. (USA)
Sanofi-Aventis SA (France)
Spectrum Pharmaceuticals, Inc. (USA)
Takeda Pharmaceutical Company Limited (Japan)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Prostate Cancer Therapeutic in each application, can be divided into
Application 1
Application 2
Application 3

Table of Contents

United States Prostate Cancer Therapeutic Market Report 2016
1 Prostate Cancer Therapeutic Overview
1.1 Product Overview and Scope of Prostate Cancer Therapeutic
1.2 Classification of Prostate Cancer Therapeutic
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Prostate Cancer Therapeutic
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Prostate Cancer Therapeutic (2011-2021)
1.4.1 USA Prostate Cancer Therapeutic Sales and Growth Rate (2011-2021)
1.4.2 USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

2 USA Prostate Cancer Therapeutic Competition by Manufacturers
2.1 USA Prostate Cancer Therapeutic Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Prostate Cancer Therapeutic Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Prostate Cancer Therapeutic Average Price by Manufactures (2015 and 2016)
2.4 Prostate Cancer Therapeutic Market Competitive Situation and Trends
2.4.1 Prostate Cancer Therapeutic Market Concentration Rate
2.4.2 Prostate Cancer Therapeutic Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 USA Prostate Cancer Therapeutic Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Prostate Cancer Therapeutic Sales and Market Share by Type (2011-2016)
3.2 USA Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)
3.3 USA Prostate Cancer Therapeutic Price by Type (2011-2016)
3.4 USA Prostate Cancer Therapeutic Sales Growth Rate by Type (2011-2016)

4 USA Prostate Cancer Therapeutic Sales (Volume) by Application (2011-2016)
4.1 USA Prostate Cancer Therapeutic Sales and Market Share by Application (2011-2016)
4.2 USA Prostate Cancer Therapeutic Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA Prostate Cancer Therapeutic Manufacturers Profiles/Analysis
5.1 Pfizer Inc. (USA)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Abbott Laboratories (USA)
5.2.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Genentech Inc. (USA)
5.3.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Genentech Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 GlaxoSmithKline Plc (UK)
5.4.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Immunomedics, Inc. (USA)
5.5.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Indevus Pharmaceuticals Inc. (USA)
5.6.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Novartis AG (Switzerland)
5.7.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 OSI Pharmaceuticals, Inc. (USA)
5.8.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Paladin Labs Inc. (Canada)
5.9.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 ALZA Corporation (USA)
5.10.2 Prostate Cancer Therapeutic Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 ALZA Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Amgen Inc. (USA)
5.12 AstraZeneca PLC (UK)
5.13 Medimmune, LLC (USA)
5.14 Bristol-Myers Squibb Company (USA)
5.15 Cell Genesys Inc. (USA)
5.16 Dendreon Corporation (USA)
5.17 EUSA Pharma, (USA) Inc. (USA)
5.18 F. Hoffmann-La Roche Ltd. (Switzerland)
5.19 Progenics Pharmaceuticals, Inc. (USA)
5.20 Sanofi-Aventis SA (France)
5.21 Spectrum Pharmaceuticals, Inc. (USA)
5.22 Takeda Pharmaceutical Company Limited (Japan)

6 Prostate Cancer Therapeutic Manufacturing Cost Analysis
6.1 Prostate Cancer Therapeutic Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prostate Cancer Therapeutic

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Prostate Cancer Therapeutic Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015
7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List

9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA Prostate Cancer Therapeutic Market Forecast (2016-2021)
10.1 USA Prostate Cancer Therapeutic Sales, Revenue Forecast (2016-2021)
10.2 USA Prostate Cancer Therapeutic Sales Forecast by Type (2016-2021)
10.3 USA Prostate Cancer Therapeutic Sales Forecast by Application (2016-2021)
10.4 Prostate Cancer Therapeutic Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Prostate Cancer Therapeutic
Table Classification of Prostate Cancer Therapeutic
Figure USA Sales Market Share of Prostate Cancer Therapeutic by Type in 2015
Table Application of Prostate Cancer Therapeutic
Figure USA Sales Market Share of Prostate Cancer Therapeutic by Application in 2015
Figure USA Prostate Cancer Therapeutic Sales and Growth Rate (2011-2021)
Figure USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)
Table USA Prostate Cancer Therapeutic Sales of Key Manufacturers (2015 and 2016)
Table USA Prostate Cancer Therapeutic Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Therapeutic Sales Share by Manufacturers
Figure 2016 Prostate Cancer Therapeutic Sales Share by Manufacturers
Table USA Prostate Cancer Therapeutic Revenue by Manufacturers (2015 and 2016)
Table USA Prostate Cancer Therapeutic Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Prostate Cancer Therapeutic Revenue Share by Manufacturers
Table 2016 USA Prostate Cancer Therapeutic Revenue Share by Manufacturers
Table USA Market Prostate Cancer Therapeutic Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Prostate Cancer Therapeutic Average Price of Key Manufacturers in 2015
Figure Prostate Cancer Therapeutic Market Share of Top 3 Manufacturers
Figure Prostate Cancer Therapeutic Market Share of Top 5 Manufacturers
Table USA Prostate Cancer Therapeutic Sales by Type (2011-2016)
Table USA Prostate Cancer Therapeutic Sales Share by Type (2011-2016)
Figure USA Prostate Cancer Therapeutic Sales Market Share by Type in 2015
Table USA Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)
Table USA Prostate Cancer Therapeutic Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostate Cancer Therapeutic by Type (2011-2016)
Table USA Prostate Cancer Therapeutic Price by Type (2011-2016)
Figure USA Prostate Cancer Therapeutic Sales Growth Rate by Type (2011-2016)
Table USA Prostate Cancer Therapeutic Sales by Application (2011-2016)
Table USA Prostate Cancer Therapeutic Sales Market Share by Application (2011-2016)
Figure USA Prostate Cancer Therapeutic Sales Market Share by Application in 2015
Table USA Prostate Cancer Therapeutic Sales Growth Rate by Application (2011-2016)
Figure USA Prostate Cancer Therapeutic Sales Growth Rate by Application (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table ALZA Corporation (USA) Basic Information List
Table ALZA Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALZA Corporation (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Amgen Inc. (USA) Basic Information List
Table Amgen Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table AstraZeneca PLC (UK) Basic Information List
Table AstraZeneca PLC (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca PLC (UK) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Medimmune, LLC (USA) Basic Information List
Table Medimmune, LLC (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Medimmune, LLC (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (USA) Basic Information List
Table Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Cell Genesys Inc. (USA) Basic Information List
Table Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Dendreon Corporation (USA) Basic Information List
Table Dendreon Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Corporation (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Basic Information List
Table EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List
Table F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List
Table Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Sanofi-Aventis SA (France) Basic Information List
Table Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List
Table Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List
Table Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Therapeutic
Figure Manufacturing Process Analysis of Prostate Cancer Therapeutic
Figure Prostate Cancer Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Therapeutic
Table Distributors/Traders List
Figure USA Prostate Cancer Therapeutic Production and Growth Rate Forecast (2016-2021)
Figure USA Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2016-2021)
Table USA Prostate Cancer Therapeutic Production Forecast by Type (2016-2021)
Table USA Prostate Cancer Therapeutic Consumption Forecast by Application (2016-2021)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *